The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial (455606)
ARTG Name
DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial
Product name
DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
daratumumab
Licence category
RE
Licence status
A
Summary